290.06 0.00 (0.00%)
After hours: 4:45PM EDT
|Bid||285.00 x 1100|
|Ask||290.14 x 900|
|Day's Range||288.95 - 297.05|
|52 Week Range||177.93 - 398.88|
|Beta (3Y Monthly)||2.72|
|PE Ratio (TTM)||62.49|
|Earnings Date||Jul 24, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||340.19|
The termination of discussion related to Straumann's iTero distribution is a setback for Align Technologies (ALGN), which is currently focusing on expanding its market base for scanners.
shares sank 5.8% to $287.91 Monday after announcing that talks had ended between the medical device company and the Straumann Group over a possible development and distribution agreement. The potential agreement had been discussed in connection with the patent settlement agreement announced by the two companies in March. The San Jose, Calif.-based company said that as part of the settlement, Straumann will pay Align an additional $16 million in lieu of the agreement.
Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Align Technology...
The termination of the Straumann agreement comes as a setback for Align Technologies (ALGN), which is currently focusing on expanding its market base for scanners.
SAN JOSE, Calif., June 13, 2019 -- Align Technology, Inc. (NASDAQ: ALGN) and Straumann Group today announced that they have terminated discussions regarding a possible.
As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and recouped their losses by the end of the first quarter. […]
The latest development in Align Technology's (ALGN) iTero arm is expected to be a perfect strategic fit for the company as it will help it further grow its patient base for intraoral scanner.
SAN JOSE, Calif., June 12, 2019 -- Align Technology, Inc. (NASDAQ: ALGN) announced today the availability of the iTero Element Foundation intraoral scanner with restorative.
Align Technology, Inc. (ALGN), today announced that Simon Beard, senior vice president and managing director for the EMEA (Europe, Middle East and Africa) region, has been appointed senior vice president and managing director for the Americas region. Markus Sebastian, vice president for our core Europe orthodontic channel has been promoted to senior vice president and managing director for the EMEA region.
Align Technology (ALGN) closed the most recent trading day at $307.66, moving +0.42% from the previous trading session.
SAN JOSE, Calif., June 03, 2019 -- Align Technology, Inc. (Nasdaq: ALGN) today announced the award of ten research grants under the company’s Annual Research Award Program. The.
Align Technology, Inc. (NASDAQ:ALGN), a large-cap worth US$24b, comes to mind for investors seeking a strong and...
Align Technology (ALGN) closed at $296.68 in the latest trading session, marking a -0.25% move from the prior day.
Warning! GuruFocus has detected 2 Warning Sign with VRTX. Vertex Pharmaceuticals Inc. (VRTX) has climbed 2.2% over the past month, 4.3% so far this year, 10.3% over the last 52 weeks and 91.2% over the past three years through May 28. Vertex has a price-earnings ratio of 20.81 versus the industry median of 28.79, a price-book ratio of 9.53 versus the industry median of 4.1 and a price-sales ratio of 13.75.
SAN JOSE, Calif., May 28, 2019 -- Align Technology, Inc. (Nasdaq: ALGN) today announced that the company is scheduled to speak at upcoming financial conferences. The.
Align Technology (ALGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Align Technology, Inc. (ALGN), today announced that Roger E. George, Align senior vice president, chief legal and regulatory officer has retired and will leave the company at the end of August 2019. Mr. George was responsible for all aspects of Align Technology's legal affairs including transactional, securities, governance, intellectual property, real estate and employment matters. Julie Coletti, Align vice president and associate general counsel, strategic commercial affairs has assumed Mr. George’s responsibilities and will work with him to ensure a smooth transition.
Align Technology (ALGN) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Balyasny Asset Management is a Chicago-based multi-strategy hedge fund that was launched by Dmitry Balyasny and Scott Schroeder back in 2001. After so many years of existence and prosperity, the fund now offers additional offices in New York, Singapore, London, and Hong Kong. It had around $12.7 billion in assets under management in March 2017. […]
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...